Study on the control of some cardiovascular risk factor of patients with acute myocardial infarction treated at 115 people’s hospital after 3 months
DOI:
https://doi.org/10.59354/ydth175.2022.20Keywords:
Acute myocardial infarction, cardiovascular risk factorsAbstract
Objectives: Study on the control proportion of LDL-C, hypertension, diabetes mellitus and smoking in patients with acute myocardial infarction after 3 months, with comparison between medical treatment and coronary intervention groups.
Subjects: 157 patients with acute myocardial infarction, including 82 patients treated by medical treatment and 75 patients treated by coronary intervention. Methods: prospective and cross-sectional descriptive study and longitudinal follow-up study after 3 months of treatment.
Results: The proportion of patients with hypertension, diabetes mellitus, dyslipidemia and smoking were 65%; 16.7%, 82.8%, 46.2%, respectively. The differences of risk factor distribution between medical treatment and coronary intervention groups were not statistically significant (with p > 0.05).
The proportion of hypertension, diabetes mellitus, dyslipidemia and smoking control of patients with acute myocardial infarction were 76.5%, 57.7%, 54.6%, 72.2%, respectively. The proportion of risk factor control between medical treatment and intervention groups were not statistically significant (with p > 0.05).
Consclusions: The control of cardiovascular risk factors of patients with acute myocardial infarction after 3 months of treatment was not good. The proportion of risk factor control between medical treatment and intervention groups were not statistically significant (with p > 0.05).
References
Mechanic, O,J,, M, Gavin, and S,A, Grossman, Acute Myocardial Infarction, in StatPearls, 2021, StatPearls Publishing, Copyright © 2021, StatPearls Publishing LLC,: Treasure Island (FL).
Mollon, L, and S, Bhattacharjee, Health related quality of life among myocardial infarction survivors in the United States: a propensity score matched analysis, Health Qual Life Outcomes, 2017, 15(1): p, 235.
Thygesen, K,, et al,, Fourth Universal Definition of Myocardial Infarction (2018), Journal of the American College of Cardiology, 2018, 72(18): p, 2231-2264.
Félix-Redondo, F,J,, et al,, Risk factors and therapeutic coverage at 6 years in patients with previous myocardial infarction: the CASTUO study, Open Heart, 2016, 3(1): p, e000368.
Nguyễn Thụy Trang, Khảo sát tình hình kiểm soát các yếu tố nguy cơ tim mạch sau can thiệp mạch vành, 2014, Đại học Y dược thành phố Hồ Chí Minh, p, 76.
Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme, Eur Heart J, 2001, 22(7): p, 554-72.
Kotseva, K,, et al,, EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries, Eur J Cardiovasc Prev Rehabil, 2009, 16(2): p, 121-37.
Võ Thị Dễ, Nghiên cứu sự tuân thủ điều trị của bệnh nhân động mạch vành đã được can thiệp, 2012, Đai học Y dược thành phố Hồ Chí Minh, p, 145.
Jankowski, P,, et al,, Secondary prevention of coronary artery disease in contemporary clinical practice, Cardiol J, 2015, 22(2): p, 219-26.
Andrikopoulos, G,, et al,, Short-term outcome and attainment of secondary prevention goals in patients with acute coronary syndrome--results from the countrywide TARGET study, Int J Cardiol, 2013, 168(2): p, 922-7
